Dermatologic Toxicities to Immunotherapy

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Dermatologic Toxicities to Immunotherapy

By University of Louisville FEATURING Alina Markova

166 views

October 9, 2023

Alina Markova, M.D., Assistant Professor of Dermatology at Weill Cornell Medical College, and Director, Inpatient ...
read more ↘ Consultative Dermatology, Co-Director, Adult and Pediatric Multidisciplinary Graft-Versus-Host Disease Clinic, and Clinical Director, Dermatology Service at Memorial Sloan Kettering Cancer Center, focused on recognizing common presentations of immune checkpoint inhibitor-associated cutaneous adverse events (ircAEs), preparing to evaluate ircAEs, and identifying the therapeutic latter for ircAEs.
↖ read less

Comments 1